does not align with AMBOSS; ceftriaxone is still used first line.
https://next.amboss.com/us/article/7t04U3?q=gonococcal%20conjunctivitis#Y4dd8e7fe93790abb60c47c8958c948f7
Both UW and AMBOSS highlight that we use third generation cephalosporins
AMBOSS clinician mode suggests ceftriaxone as the preferred choice but cefotaxime is an alternative and not inferior, they also mention avoiding ceftriaxone in premature infants
UW does the same recommending third generation cephalosporins and often listing cefotaxime in their questions (as an option)
UW 3329 says the treatment is one dose of intramuscular ceftriaxone or cefotaxime
the card isn’t wrong but it might need more clarification and as they mentioned in the rationale the image in the extra section shows cefotaxime
agree with your change to put it in extra